Bridgefront Capital, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bridgefront Capital, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2021$162,000
-57.5%
27,872
-48.7%
0.06%
-48.7%
Q1 2021$381,00054,2970.12%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders